Treatment-related myelodysplastic syndrome: molecular characteristics and therapy.

Publication Type:

Journal Article

Source:

Current opinion in hematology, Volume 18, Issue 2, p.77-82 (2011)

Keywords:

2011, Chromosome Aberrations, Clinical Research Division, Drug Therapy, Gene Expression Profiling, Genetic Predisposition to Disease, hematopoietic stem cell transplantation, Humans, Myelodysplastic Syndromes, Transplantation, Homologous

Abstract:

Treatment-related myelodysplastic syndrome (t-MDS) is a serious complication of cancer treatment. Here we review recent advances in knowledge of the risk factors, pathogenesis, and treatment of t-MDS.